{
    "balance": {
        "data": [
            "CONSOLIDATED BALANCE SHEETS\t3\tCONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS  EQUITY\t4\tCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS\t5\tNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS\t6\tItem 2.\tMANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS\t26\tItem 3.\tQUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK\t37\tItem 4.\tCONTROLS AND PROCEDURES\t37\tPART II - OTHER INFORMATION\t38\tItem 1.\tLEGAL PROCEEDINGS\t38\tItem 1A.\tRISK FACTORS\t38\tItem 2.\tUNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS\t41\tItem 6.\tEXHIBITS\t41\tINDEX TO EXHIBITS\t42\tSIGNATURES\t47\ti\tPART I   FINANCIAL INFORMATION\tItem 1.\tFINANCIAL STATEMENTS\tAMGEN INC.\tCONDENSED CONSOLIDATED STATEMENTS OF INCOME\t(In millions, except per-share data)\t(Unaudited)\tThree months ended\tMarch 31,\t2020\t2019\tRevenues:\tProduct sales\t$\t5,894\t$\t5,286\tOther revenues\t267\t271\tTotal revenues\t6,161\t5,557\tOperating expenses:\tCost of sales\t1,513\t1,055\tResearch and development\t952\t879\tSelling, general and administrative\t1,316\t1,154\tOther\t25\t(\t3\t)\tTotal operating expenses\t3,806\t3,085\tOperating income\t2,355\t2,472\tInterest expense, net\t346\t343\tInterest and other income, net\t11\t185\tIncome before income taxes\t2,020\t2,314\tProvision for income taxes\t195\t322\tNet income\t$\t1,825\t$\t1,992\tEarnings per share:\tBasic\t$\t3.09\t$\t3.20\tDiluted\t$\t3.07\t$\t3.18\tShares used in calculation of earnings per share:\tBasic\t590\t622\tDiluted\t594\t626\tSee accompanying notes.\t1\tAMGEN INC.\tCONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME\t(In millions)\t(Unaudited)\tThree months ended\tMarch 31,\t2020\t2019\tNet income\t$\t1,825\t$\t1,992\tOther comprehensive (loss) income, net of reclassification adjustments and taxes:\tLosses on foreign currency translation\t(\t52\t)\t(\t13\t)\t(Losses) gains on cash flow hedges\t(\t61\t)\t45\t(Losses) gains on available-for-sale securities\t(\t19\t)\t221\tOther\t(\t2\t)\t \tOther comprehensive (loss) income, net of taxes\t(\t134\t)\t253\tComprehensive income\t$\t1,691\t$\t2,245\tSee accompanying notes.\t2\tAMGEN INC.\tCONDENSED CONSOLIDATED BALANCE SHEETS\t(In millions, except per-share data)\tMarch 31,\t2020\tDecember 31,\t2019\t(Unaudited)\tASSETS\tCurrent assets:\tCash and cash equivalents\t$\t7,687\t$\t6,037\tMarketable securities\t325\t2,874\tTrade receivables, net\t5,009\t4,057\tInventories\t3,682\t3,584\tOther current assets\t2,110\t1,888\tTotal current assets\t18,813\t18,440\tProperty, plant and equipment, net\t4,879\t4,928\tIntangible assets, net\t18,653\t19,413\tGoodwill\t14,683\t14,703\tOther assets\t4,641\t2,223\tTotal assets\t$\t61,669\t$\t59,707\tLIABILITIES AND STOCKHOLDERS  EQUITY\tCurrent liabilities:\tAccounts payable\t$\t1,338\t$\t1,371\tAccrued liabilities\t8,649\t8,511\tCurrent portion of long-term debt\t1,840\t2,953\tTotal current liabilities\t11,827\t12,835\tLong-term debt\t30,008\t26,950\tLong-term deferred tax liabilities\t427\t606\tLong-term tax liabilities\t8,111\t8,037\tOther noncurrent liabilities\t1,811\t1,606\tContingencies and commitments\tStockholders  equity:\tCommon stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares author",
            "CONSOLIDATED BALANCE SHEETS\t(In millions, except per-share data)\tMarch 31,\t2020\tDecember 31,\t2019\t(Unaudited)\tASSETS\tCurrent assets:\tCash and cash equivalents\t$\t7,687\t$\t6,037\tMarketable securities\t325\t2,874\tTrade receivables, net\t5,009\t4,057\tInventories\t3,682\t3,584\tOther current assets\t2,110\t1,888\tTotal current assets\t18,813\t18,440\tProperty, plant and equipment, net\t4,879\t4,928\tIntangible assets, net\t18,653\t19,413\tGoodwill\t14,683\t14,703\tOther assets\t4,641\t2,223\tTotal assets\t$\t61,669\t$\t59,707\tLIABILITIES AND STOCKHOLDERS  EQUITY\tCurrent liabilities:\tAccounts payable\t$\t1,338\t$\t1,371\tAccrued liabilities\t8,649\t8,511\tCurrent portion of long-term debt\t1,840\t2,953\tTotal current liabilities\t11,827\t12,835\tLong-term debt\t30,008\t26,950\tLong-term deferred tax liabilities\t427\t606\tLong-term tax liabilities\t8,111\t8,037\tOther noncurrent liabilities\t1,811\t1,606\tContingencies and commitments\tStockholders  equity:\tCommon stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding   588.0 shares in 2020 and 591.4 shares in 2019\t31,525\t31,531\tAccumulated deficit\t(\t21,378\t)\t(\t21,330\t)\tAccumulated other comprehensive loss\t(\t662\t)\t(\t528\t)\tTotal stockholders  equity\t9,485\t9,673\tTotal liabilities and stockholders  equity\t$\t61,669\t$\t59,707\tSee accompanying notes.\t3\tAMGEN INC.\tCONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS  EQUITY\t(In millions, except per-share data)\t(Unaudited)\tNumber\tof shares\tof common\tstock\tCommon\tstock and\tadditional\tpaid-in capital\tAccumulated\tdeficit\tAccumulated\tother\tcomprehensive\tloss\tTotal\tBalance as of December 31, 2019\t591.4\t$\t31,531\t$\t(\t21,330\t)\t$\t(\t528\t)\t$\t9,673\tCumulative effect of changes in accounting principles, net of tax\t \t \t(\t2\t)\t \t(\t2\t)\tNet income\t \t \t1,825\t \t1,825\tOther comprehensive loss, net of taxes\t \t \t \t(\t134\t)\t(\t134\t)\tDividends declared on common stock ($1.60 per share)\t \t \t(\t938\t)\t \t(\t938\t)\tIssuance of common stock in connection with the Company s equity award programs\t0.9\t10\t \t \t10\tStock-based compensation expense\t \t52\t \t \t52\tTax impact related to employee stock-based compensation expense\t \t(\t68\t)\t \t \t(\t68\t)\tRepurchases of common stock\t(\t4.3\t)\t \t(\t933\t)\t \t(\t933\t)\tBalance as of March 31, 2020\t588.0\t$\t31,525\t$\t(\t21,378\t)\t$\t(\t662\t)\t$\t9,485\tNumber\tof shares\tof common\tstock\tCommon\tstock and\tadditional\tpaid-in capital\tAccumulated\tdeficit\tAccumulated\tother\tcomprehensive\tloss\tTotal\tBalance as of December 31, 2018\t629.6\t$\t31,246\t$\t(\t17,977\t)\t$\t(\t769\t)\t$\t12,500\tNet income\t \t \t1,992\t \t1,992\tOther comprehensive income, net of taxes\t \t \t \t253\t253\tDividends declared on common stock ($1.45 per share)\t \t \t(\t879\t)\t \t(\t879\t)\tIssuance of common stock in connection with the Company s equity award programs\t0.7\t6\t \t \t6\tStock-based compensation expense\t \t64\t \t \t64\tTax impact related to employee stock-based compensation expense\t \t(\t73\t)\t \t \t(\t73\t)\tRepurchases of common stock\t(\t15.9\t)\t \t(\t3,031\t)\t \t(\t3,031\t)\tBalance as of March 31, 2019\t614.4\t$\t31,243\t$\t(\t19,895\t)\t$\t(\t516\t)\t$\t10,832\tSee accompanying notes.\t4\tAMGE",
            "Consolidated Balance Sheets were as follows (in millions):\tDerivative assets\tDerivative liabilities\tMarch 31, 2020\tCondensed Consolidated\tBalance Sheets locations\tFair values\tCondensed Consolidated\tBalance Sheets locations\tFair values\tDerivatives designated as hedging instruments:\tForeign currency contracts\tOther current assets/ Other assets\t$\t375\tAccrued liabilities/ Other noncurrent liabilities\t$\t5\tCross-currency swap contracts\tOther current assets/ Other assets\t10\tAccrued liabilities/ Other noncurrent liabilities\t657\tInterest rate swap contracts\tOther current assets/ Other assets\t89\tAccrued liabilities/ Other noncurrent liabilities\t23\tTotal derivatives designated as hedging instruments\t474\t685\tDerivatives not designated as hedging instruments:\tForeign currency contracts\tOther current assets\t \tAccrued liabilities\t \tTotal derivatives not designated as hedging instruments\t \t \tTotal derivatives\t$\t474\t$\t685\tDerivative assets\tDerivative liabilities\tDecember 31, 2019\tCondensed Consolidated\tBalance Sheets locations\tFair values\tCondensed Consolidated\tBalance Sheets locations\tFair values\tDerivatives designated as hedging instruments:\tForeign currency contracts\tOther current assets/ Other assets\t$\t223\tAccrued liabilities/ Other noncurrent liabilities\t$\t31\tCross-currency swap contracts\tOther current assets/ Other assets\t66\tAccrued liabilities/ Other noncurrent liabilities\t315\tInterest rate swap contracts\tOther current assets/ Other assets\t259\tAccrued liabilities/ Other noncurrent liabilities\t \tTotal derivatives designated as hedging instruments\t548\t346\tDerivatives not designated as hedging instruments:\tForeign currency contracts\tOther current assets\t1\tAccrued liabilities\t \tTotal derivatives not designated as hedging instruments\t1\t \tTotal derivatives\t$\t549\t$\t346\tOur derivative contracts that were in liability positions as of\tMarch 31, 2020\t, contain certain credit-risk-related contingent provisions that would be triggered if (i) we were to undergo a change in control and (ii) our or the surviving entity s creditworthiness deteriorates, which is generally defined as having either a credit rating that is below investment grade or a materially weaker creditworthiness after the change in control. If these events were to occur, the counterparties would have the right but not the obligation to close the contracts under early-termination provisions. In such circumstances, the counterparties could request immediate settlement of these contracts for amounts that approximate the then current fair values of the contracts. In addition, our derivative contracts are not subject to any type of master netting arrangement, and amounts due either to or from a counterparty under the contracts may be offset against other amounts due either to or from the same counterparty only if an event of default or termination, as defined, were to occur.\tThe cash flow effects of our derivative contracts in the Condensed Consolidated Statements of Cash Flows are included in Net cash provid"
        ],
        "timestamp": "2025-01-21_09-27-11"
    }
}